Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MET
|
Steven J Goulart
EVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct | 10,292 Reduced 11.04% |
$456,964
$44.4 p/Share
|
Feb 12
2019 |
|
MET
|
Steven J Goulart
EVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,671 Added 14.39% |
$326,270
$20.82 p/Share
|
Feb 12
2019 |
|
MET
|
John D. Mc Callion
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,669 Reduced 13.0% |
$118,583
$44.43 p/Share
|
Feb 12
2019 |
|
MET
|
John D. Mc Callion
EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,861 Added 15.82% |
$80,386
$20.82 p/Share
|
Feb 12
2019 |
|
TRMK
|
Monica A Day
Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 667 Reduced 4.73% |
$19,877
$29.8 p/Share
|
Feb 12
2019 |
|
ORCC
|
Regents Of The University Of California |
BUY
Other acquisition or disposition
|
Direct | 2,670,815 Added 8.35% |
$41,130,550
$15.4 p/Share
|
Feb 12
2019 |
|
CZNC
|
J Bradley Scovill
PRESIDENT AND CEO |
BUY
Other acquisition or disposition
|
Indirect | 30 Added 1.53% |
$759
$25.31 p/Share
|
Feb 12
2019 |
|
PSDO
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,000,000 Reduced 9.08% |
$60,439,999
$15.11 p/Share
|
Feb 12
2019 |
|
SEIC
|
Wayne Withrow
EXECUTIVE VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 19.34% |
$176,500
$17.65 p/Share
|
Feb 12
2019 |
|
TNAV
|
Nokomis Capital, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50,400 Added 1.1% |
$254,016
$5.04 p/Share
|
Feb 12
2019 |
|
EGLE
|
Goldentree Asset Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 116,854 Added 1.3% |
$530,517
$4.54 p/Share
|
Feb 12
2019 |
|
EGLE
|
Goldentree Asset Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 15,070 Added 1.34% |
$68,418
$4.54 p/Share
|
Feb 12
2019 |
|
CMG
|
Pershing Square Capital Management, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 1.05% |
$11,893,000
$594.65 p/Share
|
Feb 12
2019 |
|
CBRL
|
Biglari, Sardar
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 29,325 Reduced 0.79% |
$4,972,347
$169.56 p/Share
|
Feb 12
2019 |
|
SF
|
David A Peacock |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 15.98% |
$106,280
$53.14 p/Share
|
Feb 12
2019 |
|
PRU
|
Robert Axel
SVP and Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 938 Reduced 21.21% |
$87,572
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Robert Axel
SVP and Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 2,374 Added 34.93% |
-
|
Feb 12
2019 |
|
PRU
|
Robert Falzon
EVP and Vice Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 7,114 Reduced 9.97% |
$664,163
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Robert Falzon
EVP and Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 18,984 Added 21.02% |
-
|
Feb 12
2019 |
|
PRU
|
Mark B Grier
Vice Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 15,751 Reduced 3.97% |
$1,470,513
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Mark B Grier
Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 37,967 Added 8.74% |
-
|
Feb 12
2019 |
|
PRU
|
Timothy P Harris
EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 2,935 Reduced 8.59% |
$274,012
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Timothy P Harris
EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 9,493 Added 21.73% |
-
|
Feb 12
2019 |
|
PRU
|
Barbara Koster
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 2,031 Reduced 6.62% |
$189,614
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Barbara Koster
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 6,527 Added 17.54% |
-
|
Feb 12
2019 |
|
PRU
|
Charles F Lowrey
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,390 Reduced 15.47% |
$970,010
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Charles F Lowrey
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 22,544 Added 25.13% |
-
|
Feb 12
2019 |
|
PRU
|
Stephen Pelletier
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 8,293 Reduced 27.76% |
$774,234
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Stephen Pelletier
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 21,357 Added 41.69% |
-
|
Feb 12
2019 |
|
PRU
|
Nicholas C Silitch
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 4,978 Reduced 16.51% |
$464,746
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Nicholas C Silitch
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 12,340 Added 29.04% |
-
|
Feb 12
2019 |
|
PRU
|
Scott Sleyster
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 4,045 Reduced 8.64% |
$377,641
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Scott Sleyster
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 12,340 Added 20.87% |
-
|
Feb 12
2019 |
|
PRU
|
Candace Woods
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 195 Reduced 2.72% |
$18,205
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Candace Woods
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 634 Added 8.13% |
-
|
Feb 12
2019 |
|
PRU
|
John R Strangfeld Jr
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 21,784 Reduced 6.77% |
$2,033,754
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
John R Strangfeld Jr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 47,460 Added 12.85% |
-
|
Feb 12
2019 |
|
PRU
|
Kenneth Tanji
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,039 Reduced 5.83% |
$97,001
$93.36 p/Share
|
Feb 12
2019 |
|
PRU
|
Kenneth Tanji
EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,323 Added 15.71% |
-
|
Feb 12
2019 |
|
BK
|
Lester Owens
Sr. Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 53,218 Added 50.0% |
-
|
Feb 12
2019 |
|
AMPY
|
Fir Tree Capital Management LP
Director |
SELL
Open market or private sale
|
Indirect | 1,706,949 Reduced 26.7% |
$17,069,490
$10.0 p/Share
|
Feb 12
2019 |
|
EXC
|
Paymon Aliabadi
EVP, Chief Enterprise Risk Ofr |
SELL
Open market or private sale
|
Direct | 17,500 Reduced 20.58% |
$837,900
$47.88 p/Share
|
Feb 12
2019 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 1,524 Reduced 0.04% |
$21,336
$14.0 p/Share
|
Feb 12
2019 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 432,119 Added 9.18% |
$21,606
$0.05 p/Share
|
Feb 12
2019 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 5.24% |
$3,500,000
$14.0 p/Share
|
Feb 12
2019 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
BUY
Conversion of derivative security
|
Indirect | 3,521,767 Added 28.86% |
-
|
Feb 12
2019 |
|
HARP
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 127,096 Added 3.37% |
$6,355
$0.05 p/Share
|
Feb 12
2019 |
|
HARP
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 250,000 Added 6.03% |
$3,500,000
$14.0 p/Share
|
Feb 12
2019 |
|
HARP
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 3,521,773 Added 50.0% |
-
|
Feb 12
2019 |
|
HARP
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 447 Reduced 0.01% |
$6,258
$14.0 p/Share
|
Feb 12
2019 |